ORG Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$43K Sell
451
-75
-14% -$7.35K 0.01% 612
2025
Q3
$51.3K Buy
526
+86
+20% +$8.91K 0.01% 576
2025
Q2
$46.1K Buy
440
+312
+244% +$31.6K 0.01% 563
2025
Q1
$12.9K Buy
128
+25
+24% +$2.52K ﹤0.01% 753
2024
Q4
$9.18K Sell
103
-1
-1% -$88 ﹤0.01% 911
2024
Q3
$8.7K Sell
104
-1,073
-91% -$84.6K ﹤0.01% 810
2024
Q2
$89.9K Buy
1,177
+1,158
+6,095% +$84.8K 0.01% 628
2024
Q1
$1.29K Sell
19
-995
-98% -$64K ﹤0.01% 426
2023
Q4
$58.6K Buy
1,014
+874
+624% +$46.7K 0.01% 491
2023
Q3
$7.37K Sell
140
-20
-13% -$1.05K ﹤0.01% 881
2023
Q2
$8.55K Buy
+160
New +$8.36K ﹤0.01% 1000

Other funds holding BSX

ORG Partners's BSX Position: Q4 2025 in Review

ORG Partners reduced its Boston Scientific (BSX) stake by 14% in Q4 2025, selling an estimated $7.35K and leaving 451 shares worth $43K. The position accounts for 0.01% of the portfolio, ranked #612.

ORG Partners first reported a position in BSX in Q2 2023 and has held it in 11 quarters since. The position peaked at $89.9K in Q2 2024. 1,791 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • ORG Partners held 451 shares of Boston Scientific worth $43K as of Q4 2025.
  • ORG Partners sold 75 Boston Scientific shares in Q4 2025, an estimated $7.35K.
  • Boston Scientific made up 0.01% of ORG Partners's portfolio in Q4 2025, its #612 holding.
  • ORG Partners first reported a position in Boston Scientific in Q2 2023 and has held it in 11 quarters since.
  • ORG Partners's Boston Scientific position peaked at $89.9K in Q2 2024.
  • 1,791 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.